A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Clinical trial NCT06857955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06857955
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2027-01-29
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.